L. Dihel

Oxidative Metabolism of the Trifluoromethoxy Moiety of OSI-930

W. W. Johnson, K. Mulvihill, L. Dihel, 2009, Drug metabolism and drug interactions.

Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecan.

D. Baccanari, S. Gill, D. Emerson, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cloning and sequencing of papain-encoding cDNA.

V. Coghlan, L. Dihel, L. W. Cohen, 1986, Gene.

Safety Assessment of 4′-Thio-β-d-Arabinofuranosylcytosine in the Beagle Dog Suggests a Drug-Induced Centrally Mediated Effect on the Hypothalamic-Pituitary-Adrenal Axis

D. Colagiovanni, D. Drolet, K. Hart, 2006, International journal of toxicology.

Biodistribution of NX211, liposomal lurtotecan, in tumor-bearing mice

D. Emerson, M. Ptaszynski, B. Tomkinson, 2001, Anti-cancer drugs.

Synthesis of papain in Escherichia coli.

L. Dihel, L. W. Cohen, C. Fluharty, 1990, Gene.

Derivation of RNA aptamer inhibitors of human complement C5.

R A Bendele, G Biesecker, L Dihel, 1999, Immunopharmacology.